Animal models of amyloid-beta-related pathologies in Alzheimer's disease
- PMID: 20136653
- DOI: 10.1111/j.1742-4658.2010.07564.x
Animal models of amyloid-beta-related pathologies in Alzheimer's disease
Abstract
In the early 1990s, breakthrough discoveries on the genetics of Alzheimer's disease led to the identification of missense mutations in the amyloid-beta precursor protein gene. Research findings quickly followed, giving insights into molecular pathogenesis and possibilities for the development of new types of animal models. The complete toolbox of transgenic techniques, including pronuclear oocyte injection and homologous recombination, has been applied in the Alzheimer's disease field, to produce overexpressors, knockouts, knockins and regulatable transgenics. Transgenic models have dramatically advanced our understanding of pathogenic mechanisms and allowed therapeutic approaches to be tested. Following a brief introduction to Alzheimer's disease, various nontransgenic and transgenic animal models are described in terms of their values and limitations with respect to pathogenic, therapeutic and functional understandings of the human disease.
Similar articles
-
Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.Eur J Neurosci. 2004 May;19(10):2826-38. doi: 10.1111/j.0953-816X.2004.03397.x. Eur J Neurosci. 2004. PMID: 15147316
-
Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.Neuroscientist. 2007 Feb;13(1):38-48. doi: 10.1177/1073858406295610. Neuroscientist. 2007. PMID: 17229974 Review.
-
Therapeutic targets from a Drosophila model of Alzheimer's disease.Curr Opin Pharmacol. 2004 Oct;4(5):513-6. doi: 10.1016/j.coph.2004.07.001. Curr Opin Pharmacol. 2004. PMID: 15351357 Review.
-
The amyloid peptide and its precursor in Alzheimer's disease.Rev Neurosci. 1995 Oct-Dec;6(4):287-316. Rev Neurosci. 1995. PMID: 8845971 Review.
-
Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.Ann Neurol. 1994 Apr;35(4):432-8. doi: 10.1002/ana.410350410. Ann Neurol. 1994. PMID: 8154870
Cited by
-
Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer's Disease.Vaccines (Basel). 2021 Apr 15;9(4):388. doi: 10.3390/vaccines9040388. Vaccines (Basel). 2021. PMID: 33920929 Free PMC article. Review.
-
Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease.Neuroreport. 2011 Aug 24;22(12):623-7. doi: 10.1097/WNR.0b013e3283497334. Neuroreport. 2011. PMID: 21734608 Free PMC article.
-
Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease.Adv Pharmacol. 2012;64:303-25. doi: 10.1016/B978-0-12-394816-8.00009-X. Adv Pharmacol. 2012. PMID: 22840751 Free PMC article. Review.
-
Alzheimer's disease: pathological mechanisms and recent insights.Curr Neuropharmacol. 2011 Dec;9(4):674-84. doi: 10.2174/157015911798376181. Curr Neuropharmacol. 2011. PMID: 22654725 Free PMC article.
-
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models.Clinics (Sao Paulo). 2011;66 Suppl 1(Suppl 1):45-54. doi: 10.1590/s1807-59322011001300006. Clinics (Sao Paulo). 2011. PMID: 21779722 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical